Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Simultaneous LC-MS/MS screening of 222 drugs of abuse in eight solid food matrices using a unified QuEChERS-Based approach.

Regulatory toxicology and pharmacology : RTP·2026

Same author

Reusable octenidine-loaded polyetherimide nanofiber filter membranes for efficient air filtration and airborne bacteria inactivation.

Journal of hazardous materials·2026

Same author

Liquid-liquid extraction coupled with LC-MS/MS for multi-residue screening of 223 drugs of abuse in high-sugar confectionery products.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026

Same author

Benzyl-Spacer-Engineered Prodrug: Enabling NIR Fluorescent Activation for Cancer Therapy in a Zebrafish Gallbladder Model.

Journal of medicinal chemistry·2026

Same author

Comparison of early and late surgical ligation of patent ductus arteriosus in preterm infants.

Medicine·2026

Same author

Hydrophobic Polymer-Coated and Uncoated ZIF-67/Alumina Membrane for Volatile Organic Compound Degradation and CO<sub>2</sub> Adsorption Capture.

ChemSusChem·2026

Same journal

Development of Indole-3-yl-methylene-thiobarbital Derivatives as Inhibitors of HDAC8 Enzyme Activity.

Journal of medicinal chemistry·2026

Same journal

Discovery of a Potent NAMPT-Targeting PROTAC for the Suppression of Triple-Negative Breast Cancer via Macrophage Reprogramming.

Journal of medicinal chemistry·2026

Same journal

3',4'-Isopropylidene-α-galactosylceramide Enables Multidose Th1 Adjuvanticity Despite Limited Serial Serum IFN-γ Responsiveness.

Journal of medicinal chemistry·2026

Same journal

A Bioorthogonally Cleavable <i>N</i>-Oxide Linker for Prodrug Design: Elucidating the Structure-Cyclization Kinetics Relationships for Controlled Drug Release.

Journal of medicinal chemistry·2026

Same journal

A Melatonin-Catechol Hybrid Molecule Prolongs Lifespan via Regulating ROS and Reprogramming Mitochondrial Metabolism.

Journal of medicinal chemistry·2026

Same journal

Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration.

Journal of medicinal chemistry·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 23, 2025

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

Transforming Small-Molecule Nanoaggregation into Functional Drug Delivery Platforms.

JunHyuk Kim¹, Arun Dattatray Kulthe¹, Su Jeong Park¹

¹Institute of Applied Chemistry and Department of Chemistry, Hallym University, Chuncheon 24252, Republic of Korea.

Journal of Medicinal Chemistry

|May 2, 2025

Summary

This summary is machine-generated.

Researchers developed Nano-CC1-Acl, a novel nanoaggregate from benzimidazole derivatives, for targeted cancer therapy. This drug delivery platform disassembles in response to biothiols, releasing a potent microtubule-targeting agent for enhanced anticancer activity.

More Related Videos

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Published on: August 11, 2018

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Related Experiment Videos

Last Updated: May 23, 2025

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Published on: August 11, 2018

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Area of Science:

Nanotechnology in Medicine
Drug Delivery Systems
Cancer Therapeutics

Background:

Stimuli-responsive nanoaggregates offer potential for improved cancer therapy selectivity and efficacy.
Spontaneous self-assembly of small organic molecules into nanoscale aggregates presents a challenge in drug discovery.
This self-assembly can be engineered into functional drug delivery platforms.

Purpose of the Study:

To engineer a nanoaggregate, Nano-CC1-Acl, for targeted anticancer activity.
To investigate the self-assembly properties and drug release mechanism of CC1-Acl.
To evaluate the efficacy of Nano-CC1-Acl as a cancer therapeutic.

Main Methods:

Synthesis and characterization of benzimidazole derivatives CC1 and CC1-Acl.
Self-assembly studies in aqueous environments to form nanoaggregates Nano-CC1 and Nano-CC1-Acl.
Evaluation of nanoaggregate size, IC50 values, and disassembly triggered by cysteine (a biothiol).

Main Results:

Nano-CC1-Acl (110.6 ± 23.1 nm) demonstrated significantly lower IC50 values (2.88-3.40 μM) compared to Nano-CC1 (>100 μM).
The IC50 of Nano-CC1-Acl decreased to 0.20 ± 0.16 μM in the presence of cysteine.
Intracellular biothiols triggered Nano-CC1-Acl disassembly, releasing CC1, a microtubule-targeting agent.

Conclusions:

Small molecule nanoaggregation can be leveraged to create functional drug delivery platforms.
Nano-CC1-Acl exhibits targeted anticancer activity through biothiol-triggered disassembly and release of CC1.
This approach holds promise for developing advanced cancer therapeutics.